PHARMATECA » №s5-13 / 2013

V.V. Fomin Opening remarks
N.Yu. Karpova, M.A. Rashid, N.A. Shostak, T.V. Kazakova CARDIOVASCULAR DISEASES AND OSTEOPOROSIS	8-13
I.A. Baranova OSTEOPOROSIS IN PRACTICE OF PULMONOLOGIST	14-20
E.V. Biryukova DO WE KNOW EVERYTHING ABOUT TREATMENT OF STEROID-INDUCED OSTEOPOROSIS?	22-27
N.A. Shostak, A.A. Kondrashov, A.A. Muradyants, V.S. Shemenkova OSTEOPOROSIS IN MEN: APPROACHES TO THERAPY FROM THE PERSPECTIVE OF CURRENT POSITION	28-32
E.G. Zotkin, Yu.A. Safonova, S.Yu. Shkireyeva AGE-RELATED SARCOPENIA: DEFINITION, DIAGNOSIS AND APPROACHES TO THE PREVENTION	33-38
V.N. Shishkova THE USE OF VITAMIN D IN ELDERLY PATIENTS OR POSTMENOPAUSAL WOMEN: THE UPDATE OF RECOMMENDATIONS OF EUROPEAN SOCIETY ON CLINICAL AND ECONOMIC ASPECTS OF OSTEOPOROSIS AND OSTEOARTHRITIS (ESCEO, 2013)	39-42
S. S. Apetov, S.Yu. Kalinchenko THE ROLE OF SEX HORMONES, ANDROGENS AND ESTROGENS, IN THE PREVENTION AND TREATMENT OF OSTEOPOROSIS IN MEN AND WOMEN	43-45
A.V. Ledina, V.N. Prilepskaya PREVENTION AND TREATMENT OF OSTEOPOROSIS IN PREGNANT WOMEN	46-48
N.Zakharova, T.M. Tvorogova, A.S.Vorobyova CORRECTION OF OSTEOPENIA IN ADOLESCENTS WITH DISEASES OF UPPER GASTROINTESTINAL TRACT	49-55